Eloralintide
A Study of Eloralintide (LY3841136) in Female Participants With Obesity or Overweight
Eli Lilly · Phase 1 · Recruiting · Enrollment 34
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Eloralintide and combined oral contraceptive | Obesity or overweight | n/r | n/r | n/r | n/r |